Trials / Recruiting
RecruitingNCT06444360
Behavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active Adolescents and Young Adults
Hybrid Type 2 Effectiveness-Implementation Trial of Status Neutral, Integrated Behavioral Activation and Risk Reduction Intervention for Stimulant Use Among Sexually Active Adolescents and Young Adults (Project IMPACT)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 360 (estimated)
- Sponsor
- Westat · Academic / Other
- Sex
- All
- Age
- 16 Years – 24 Years
- Healthy volunteers
- Accepted
Summary
The use of behavioral intervention to reduce stimulant use and concurrent HIV sexual transmission risk.
Detailed description
IMPACT is a Human Immunodeficiency Virus (HIV) status-neutral, behavioral intervention to reduce stimulant use and concurrent HIV sexual transmission risk. This study will evaluate the effectiveness of IMPACT and determine feasibility of implementing IMPACT for translation into real-world practice using a hybrid effectiveness-implementation design. The IMPACT intervention includes 10 sessions: 2 sessions of HIV sexual risk reduction (RR) counseling, 1 session focused on orienting and rationale of behavioral activation (BA), 6 sessions integrating BA and sexual RR counseling-including pre-exposure prophylaxis (PrEP) or antiretroviral therapy (ART) and HIV care-and 1 final session on strategies for slip-ups and recurrence management. The enhanced Standard of Care (eSOC) group includes two HIV sexual RR sessions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | IMPACT | The IMPACT intervention includes 10 sessions: 2 sessions of HIV sexual risk reduction (RR) counseling, 1 session focused on orienting and rationale of behavioral activation (BA), 6 sessions integrating BA and sexual RR counseling (including PrEP or ART and HIV care), and 1 final session on strategies for slip-ups and recurrence management. |
| BEHAVIORAL | eSOC | The eSOC group includes 2 sessions of HIV sexual RR counseling. |
Timeline
- Start date
- 2025-11-04
- Primary completion
- 2028-07-31
- Completion
- 2028-07-31
- First posted
- 2024-06-05
- Last updated
- 2026-01-12
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT06444360. Inclusion in this directory is not an endorsement.